Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.6B | 1.4B | 1.5B |
Cost of revenue | 258.9M | 264.1M | 251.9M | 259.4M |
Gross profit | 1.2B | 1.3B | 1.2B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.0B | 1.0B | 973.1M | 957.9M |
Other operating expenses | 130.8M | 141.4M | 117.7M | 115.3M |
Operating income | 67.1M | 157.6M | 70.4M | 102.0M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 14.2M | 13.5M | 14.6M | 18.2M |
Other income expense | 21.3M | 23.2M | 1.3M | -1.6M |
Pretax income | 74.2M | 167.2M | 57.1M | 82.2M |
Tax provision | 15.2M | 26.4M | 11.1M | 15.2M |
Net income | 59.0M | 140.9M | 46.0M | 67.0M |
Basic EPS | 0.3 | — | 0.2 | 0.3 |
Diluted EPS | 0.3 | — | 0.2 | 0.3 |
Basic average shares | 140.1M | — | 137.1M | 141.0M |
Diluted average shares | 140.7M | — | 137.5M | 141.0M |
EBITDA | 124.6M | 218.6M | 110.0M | 138.6M |
Net income from continuing op. | 59.0M | 140.9M | 46.0M | 67.0M |
Minority interests | -17.6M | -26.7M | -19.7M | -24.2M |
Preferred stock dividends | — | — | — | — |